Park West Asset Management’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
Other funds holding PROK
ACA
SC
KC
GL
MF
Park West Asset Management's PROK Position: Q1 2022 in Review
Park West Asset Management sold out of ProKidney (PROK) in Q1 2022, closing a stake of 1,100,000 shares — an estimated $10.9M sold.
Park West Asset Management first reported a position in PROK in Q2 2021 and held it in 3 quarters. The position peaked at $11.1M in Q2 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.
- Park West Asset Management reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
- Park West Asset Management sold 1,100,000 ProKidney shares in Q1 2022, an estimated $10.9M.
- Park West Asset Management first reported a position in ProKidney in Q2 2021 and held it in 3 quarters.
- Park West Asset Management's ProKidney position peaked at $11.1M in Q2 2021.
- 80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.
Based on Park West Asset Management's 13F filing for Q1 2022, filed 16 May 2022.